11 results match your criteria: "Helsinki University Hospital Heart and Lung Center[Affiliation]"

Introduction: Both physicians and patients are increasingly aware of the environmental impacts of medication. The shift of treatment paradigm towards MART-treatment (Maintenance and Reliever Therapy) in asthma affects the treatment-related emissions. The carbon footprint of inhaled medication is also tied to the type of the device used.

View Article and Find Full Text PDF

Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients.

JACC Heart Fail

October 2024

Oslo University Hospital Rikshospitalet, Oslo, Norway; KG Jebsen Center for Cardiac Research, University of Oslo, Oslo, Norway.

Article Synopsis
  • Cardiac allograft vasculopathy is a serious condition affecting heart transplant patients, characterized by increased thickness of coronary arteries, and despite using statins, it remains a top cause of death.
  • A clinical trial was conducted to investigate whether the cholesterol-lowering drug evolocumab could reduce this condition's severity in heart transplant recipients.
  • Though evolocumab significantly lowered LDL cholesterol levels in participants, it did not lead to a reduction in the thickness of coronary arteries after 12 months, and safety was not compromised during the study.
View Article and Find Full Text PDF
Article Synopsis
  • Chronotropic incompetence (CI) is a condition often seen in elderly patients with cardiac resynchronization therapy pacemakers, impacting their exercise performance.
  • This study followed older patients after CRT-P implantation, identifying CI in 75% of them and demonstrating the benefits of a rate-adaptive pacing mode using a minute ventilation sensor.
  • The results showed significant improvements in walking distance and heart rate response, indicating that optimized pacing can enhance exercise tolerance in these patients.
View Article and Find Full Text PDF

Objectives: Mental health conditions (MHCs) have been associated with undertreatment of unrelated medical conditions, but whether patients with MHCs face disparities in receiving rhythm control therapies for atrial fibrillation (AF) is currently unknown. We assessed the hypothesis that MHCs are associated with a lower use of antiarrhythmic therapies (AATs).

Design: A nationwide retrospective registry-based cohort study.

View Article and Find Full Text PDF

Background: Continuous positive airway pressure (CPAP) mask renewal policies vary inside and between countries. There are no independent studies on the optimal mask renewal frequency. We aimed to evaluate CPAP mask function over time in a real-life clinical setting, and to compare the results against current renewal policies.

View Article and Find Full Text PDF

Background: Exposures leading to irritant-induced asthma (IIA) are poorly documented.

Methods: We retrospectively screened the medical records of patients with IIA diagnosed in an occupational medicine clinic during 2000-2018. We classified the cases into acute (onset after single exposure) and subacute (onset after multiple exposures) IIA.

View Article and Find Full Text PDF

Background: Cardiac allograft vasculopathy (CAV) is characterized by diffuse thickening of the arterial intima. Statins reduce the incidence of CAV, but despite the use of statins, CAV remains one of the leading causes of long-term death after heart transplant. Inhibitors of proprotein convertase subtilisin-kexin type 9 (PCSK9) substantially reduce cholesterol levels but have not been tested in heart transplant recipients.

View Article and Find Full Text PDF

Trait-like sensitivity to stress in long QT syndrome patients has been documented previously. In addition, mental stress has been associated with symptomatic status of long QT syndrome. We examined whether the symptomatic type 1 long QT syndrome patients would be more sensitive to mental stress compared to asymptomatic patients and whether there would be differences in task-related physiological stress reactions between type 1 long QT syndrome patients and healthy individuals.

View Article and Find Full Text PDF

Estimating the effectiveness of pulmonary rehabilitation for COPD exacerbations: reduction of hospital inpatient days during the following year.

Int J Chron Obstruct Pulmon Dis

June 2018

Department of Pulmonary Diseases and Clinical Allergology, Turku University Hospital, University of Turku, Turku, Finland.

Aims: To study the short- and long-term results of pulmonary rehabilitation (PR) given in the Helsinki University Heart and Lung Center and to understand the hospital resources used to treat severe COPD exacerbations in the city of Helsinki.

Materials And Methods: Seventy-eight inactive patients with severe COPD were recruited for a PR course; three of them did not finish the course. The course took 6-8 weeks and included 11-16 supervised exercise sessions.

View Article and Find Full Text PDF

Background: This study presents a retrospective evaluation of patient, disease, and treatment features predicting long-term survival and health-related quality of life (HRQoL) among patients who underwent surgery for non-small cell lung cancer (NSCLC).

Methods: Between January 2000 and June 2009, 586 patients underwent surgery at the Helsinki University Hospital. The 276 patients still alive in June 2011 received two validated quality of life questionnaires (QLQ): the generic 15D and the cancer-specific EORTC QLQ-C30 + QLQ-LC13.

View Article and Find Full Text PDF